Risk Factors for Type 2 Diabetes Combined with Metabolic Inflammatory Syndrome
1.Graduate School,Liaoning University of Traditional Chinese Medicine,Shenyang 110032,China
2.Department of Endocrinology,Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110032,China
*Corresponding author: WANG Mei,Chief physician,Master supervisor;E-mail: wm896464@163.com
[1]HOTAMISLIGIL G S.Inflammation and metabolic disorders[J].Nature,2006,444(7121):860-867.DOI:10.1038/nature05485.
[2]TCHKONIA T,THOMOU T,ZHU Y,et al.Mechanisms and metabolic implications of regional differences among fat depots[J].Cell Metab,2013,17(5):644-656.DOI:10.1016/j.cmet.2013.03.008.
[3]GRANT R W,DIXIT V D.Adipose tissue as an immunological organ[J].Obesity(Silver spring),2015,23(3):512-518.DOI:10.1002/oby.21003.
[4]MCCULLOUGH A J.The clinical features,diagnosis and natural history of non- alcoholic fatty liver disease[J].Clin Liver Dis,2004,8:521-533.
[5]POVERO D,FELDSTEIN A E.Novel molecular mechanisms in the development of non-alcoholic steatohepatitis[J].Diabetes Metab J,2016,40:1-11.
[6]胡仁明,谢颖,鹿斌,等.2型糖尿病患者高发“代谢性炎症综合征”[J].中华内分泌代谢杂志,2016,32(1):27-32.DOI:10.3760/cma.j.issn.1000-6699.2016.01.008.
HU R M,XIE Y,LU B,et al.High detective rate of "metabolic inflammatory syndrome" in patients with type 2 diabetes[J].Chinese Journal of Endocrinology and Metabolism,2016,32(1):27-32.DOI:10.3760/cma.j.issn.1000-6699.2016.01.008.
[7]钱荣立.关于糖尿病的新诊断标准与分型[J].中国糖尿病杂志,2000,8(1):5-6.DOI:10.3321/j.issn:1006-6187.2000.01.001.
QIAN R L.New criteria of diagosis and typing of diabetes mellitus[J].Chinese Journal of Diabetes,2000,8(1):5-6.DOI:10.3321/j.issn:1006-6187.2000.01.001.
[8]ALBERTI K G,ZIMMET P,SHAW J,et al.The metabolic syndrome-a new worldwide definition [J].Lancet,2005,366(9491):1059-1062.?DOI:10.1016/S0140-6736(05)67402-8.
[9]DONATH M Y,SHOELSON S E.Type 2 diabetes as an inflammatory disease[J].Nat Rev Immunol,2011,11(2):98-107.DOI:10.1038/nri2925.
[10]DALAMAGA M,KARMANIOLAS K,CHAMBERLAND J,et al.Higherfetuin-A,loweradiponectin and free leotun levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome[J].Metabolism,2013,62(12):1830-1839.
[11]KAUR J.A comprehensive review on meteabolic syndrome[J].Cardiol Res Pract,2014,2014:943162.
[12]ANAN F,TAKAHASHI N,NAKAGAWA M,et al.High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients[J].Metab,2005,54(4):552-558.
[13]DONG Y,LIANG G,YUAN B,et al.MALATI promotes the proliferation and metastasis of osteosarcoma cells by activating PI3K/Akt pathway[J].Tumour Biol,2015,36(3):1477-1478.DOI:10.1007/s13277-014-2631-4.
[14]GENC H,DOGRU T,KARA M,et al.Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease[J].Ann Hepatol,2013,12(4):548-555.
[15]BLUHER M,UNGER R,RESSOUL F,et al.Relation between glycaemic control,hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or type 2 diabetes[J].Diaberologia,2002,45(2):210-216.
[16]YAMAKAWA L,KOLIMA H,TERASHIMA T,et al.Inactination of TNF-alpha ameliorates diabetic neuropathy in mice[J].Am J Physiol Endocrinol Metab,2011,301:844-852.
[17]CHEN L,LI B,CHEN B,et al.Thymoquinone alleviates the experimental diabetic peripheral neuropathy by modulation of inflammation[J].Scientific Reports,2016,6:31656.